カテゴリー： QYResearch, 世界

世界のトリプルネガティブ乳癌治療市場 2019年

【英語タイトル】Global Triple-Negative Breast Cancer Treatment Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16858）・商品コード：DATA909X16858
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、トリプルネガティブ乳癌治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アルキル化剤、植物製品、微生物製品、代謝拮抗剤、微小管安定剤に、用途別には、病院薬局、小売薬局にセグメント区分し、トリプルネガティブ乳癌治療の世界市場を分析しました。


・エグゼクティブ・サマリー
・トリプルネガティブ乳癌治療の世界市場概要
・トリプルネガティブ乳癌治療の製造コスト構成分析
・トリプルネガティブ乳癌治療の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・トリプルネガティブ乳癌治療の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・トリプルネガティブ乳癌治療のセグメント分析（種類別）
（アルキル化剤、植物製品、微生物製品、代謝拮抗剤、微小管安定剤）
・トリプルネガティブ乳癌治療のセグメント分析（用途別）
（病院薬局、小売薬局）
・トリプルネガティブ乳癌治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Celgene、Roche、Immunomedics GmbH、Merck & Co., Inc.、F. Hoffmann-La Roche Ltd、Eisai Co., Ltd、）
・トリプルネガティブ乳癌治療の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Triple-Negative Breast Cancer Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Triple-Negative Breast Cancer Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Triple-Negative Breast Cancer Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Triple-Negative Breast Cancer Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Triple-Negative Breast Cancer Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Celgene
Roche
Immunomedics GmbH
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
Eisai Co., Ltd
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Alkylating Agents
Plant Products
Microorganism Products
Antimetabolites
Microtubule Stablizing Agents

Segment by Application
Hospital Pharmacies
Retail Pharmacies

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Triple-Negative Breast Cancer Treatment
1.1 Definition of Triple-Negative Breast Cancer Treatment
1.2 Triple-Negative Breast Cancer Treatment Segment by Type
1.2.1 Global Triple-Negative Breast Cancer Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Alkylating Agents
1.2.3 Plant Products
1.2.4 Microorganism Products
1.2.5 Antimetabolites
1.2.6 Microtubule Stablizing Agents
1.3 Triple-Negative Breast Cancer Treatment Segment by Applications
1.3.1 Global Triple-Negative Breast Cancer Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Triple-Negative Breast Cancer Treatment Overall Market
1.4.1 Global Triple-Negative Breast Cancer Treatment Revenue (2014-2025)
1.4.2 Global Triple-Negative Breast Cancer Treatment Production (2014-2025)
1.4.3 North America Triple-Negative Breast Cancer Treatment Status and Prospect (2014-2025)
1.4.4 Europe Triple-Negative Breast Cancer Treatment Status and Prospect (2014-2025)
1.4.5 China Triple-Negative Breast Cancer Treatment Status and Prospect (2014-2025)
1.4.6 Japan Triple-Negative Breast Cancer Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Triple-Negative Breast Cancer Treatment Status and Prospect (2014-2025)
1.4.8 India Triple-Negative Breast Cancer Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Triple-Negative Breast Cancer Treatment
2.3 Manufacturing Process Analysis of Triple-Negative Breast Cancer Treatment
2.4 Industry Chain Structure of Triple-Negative Breast Cancer Treatment

3 Development and Manufacturing Plants Analysis of Triple-Negative Breast Cancer Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Triple-Negative Breast Cancer Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Triple-Negative Breast Cancer Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Triple-Negative Breast Cancer Treatment Production and Capacity Analysis
4.2 Triple-Negative Breast Cancer Treatment Revenue Analysis
4.3 Triple-Negative Breast Cancer Treatment Price Analysis
4.4 Market Concentration Degree

5 Triple-Negative Breast Cancer Treatment Regional Market Analysis
5.1 Triple-Negative Breast Cancer Treatment Production by Regions
5.1.1 Global Triple-Negative Breast Cancer Treatment Production by Regions
5.1.2 Global Triple-Negative Breast Cancer Treatment Revenue by Regions
5.2 Triple-Negative Breast Cancer Treatment Consumption by Regions
5.3 North America Triple-Negative Breast Cancer Treatment Market Analysis
5.3.1 North America Triple-Negative Breast Cancer Treatment Production
5.3.2 North America Triple-Negative Breast Cancer Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Triple-Negative Breast Cancer Treatment Import and Export
5.4 Europe Triple-Negative Breast Cancer Treatment Market Analysis
5.4.1 Europe Triple-Negative Breast Cancer Treatment Production
5.4.2 Europe Triple-Negative Breast Cancer Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Triple-Negative Breast Cancer Treatment Import and Export
5.5 China Triple-Negative Breast Cancer Treatment Market Analysis
5.5.1 China Triple-Negative Breast Cancer Treatment Production
5.5.2 China Triple-Negative Breast Cancer Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Triple-Negative Breast Cancer Treatment Import and Export
5.6 Japan Triple-Negative Breast Cancer Treatment Market Analysis
5.6.1 Japan Triple-Negative Breast Cancer Treatment Production
5.6.2 Japan Triple-Negative Breast Cancer Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Triple-Negative Breast Cancer Treatment Import and Export
5.7 Southeast Asia Triple-Negative Breast Cancer Treatment Market Analysis
5.7.1 Southeast Asia Triple-Negative Breast Cancer Treatment Production
5.7.2 Southeast Asia Triple-Negative Breast Cancer Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Triple-Negative Breast Cancer Treatment Import and Export
5.8 India Triple-Negative Breast Cancer Treatment Market Analysis
5.8.1 India Triple-Negative Breast Cancer Treatment Production
5.8.2 India Triple-Negative Breast Cancer Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Triple-Negative Breast Cancer Treatment Import and Export

6 Triple-Negative Breast Cancer Treatment Segment Market Analysis (by Type)
6.1 Global Triple-Negative Breast Cancer Treatment Production by Type
6.2 Global Triple-Negative Breast Cancer Treatment Revenue by Type
6.3 Triple-Negative Breast Cancer Treatment Price by Type

7 Triple-Negative Breast Cancer Treatment Segment Market Analysis (by Application)
7.1 Global Triple-Negative Breast Cancer Treatment Consumption by Application
7.2 Global Triple-Negative Breast Cancer Treatment Consumption Market Share by Application (2014-2019)

8 Triple-Negative Breast Cancer Treatment Major Manufacturers Analysis
8.1 Celgene
8.1.1 Celgene Triple-Negative Breast Cancer Treatment Production Sites and Area Served
8.1.2 Celgene Product Introduction, Application and Specification
8.1.3 Celgene Triple-Negative Breast Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Roche
8.2.1 Roche Triple-Negative Breast Cancer Treatment Production Sites and Area Served
8.2.2 Roche Product Introduction, Application and Specification
8.2.3 Roche Triple-Negative Breast Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Immunomedics GmbH
8.3.1 Immunomedics GmbH Triple-Negative Breast Cancer Treatment Production Sites and Area Served
8.3.2 Immunomedics GmbH Product Introduction, Application and Specification
8.3.3 Immunomedics GmbH Triple-Negative Breast Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Merck & Co., Inc.
8.4.1 Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Production Sites and Area Served
8.4.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.4.3 Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 F. Hoffmann-La Roche Ltd
8.5.1 F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Production Sites and Area Served
8.5.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
8.5.3 F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eisai Co., Ltd
8.6.1 Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Production Sites and Area Served
8.6.2 Eisai Co., Ltd Product Introduction, Application and Specification
8.6.3 Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Triple-Negative Breast Cancer Treatment Market
9.1 Global Triple-Negative Breast Cancer Treatment Market Trend Analysis
9.1.1 Global Triple-Negative Breast Cancer Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Triple-Negative Breast Cancer Treatment Regional Market Trend
9.2.1 North America Triple-Negative Breast Cancer Treatment Forecast 2019-2025
9.2.2 Europe Triple-Negative Breast Cancer Treatment Forecast 2019-2025
9.2.3 China Triple-Negative Breast Cancer Treatment Forecast 2019-2025
9.2.4 Japan Triple-Negative Breast Cancer Treatment Forecast 2019-2025
9.2.5 Southeast Asia Triple-Negative Breast Cancer Treatment Forecast 2019-2025
9.2.6 India Triple-Negative Breast Cancer Treatment Forecast 2019-2025
9.3 Triple-Negative Breast Cancer Treatment Market Trend (Product Type)
9.4 Triple-Negative Breast Cancer Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Triple-Negative Breast Cancer Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Triple-Negative Breast Cancer Treatment
Table Global Triple-Negative Breast Cancer Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Triple-Negative Breast Cancer Treatment Production Market Share by Types in 2018
Figure Alkylating Agents Product Picture
Figure Plant Products Product Picture
Figure Microorganism Products Product Picture
Figure Antimetabolites Product Picture
Figure Microtubule Stablizing Agents Product Picture
Table Global Triple-Negative Breast Cancer Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Triple-Negative Breast Cancer Treatment Consumption Market Share by Applications in 2018
Figure Hospital Pharmacies
Figure Retail Pharmacies
Figure Global Triple-Negative Breast Cancer Treatment Revenue (Million USD) (2014-2025)
Figure Global Triple-Negative Breast Cancer Treatment Production (K Pcs) (2014-2025)
Figure North America Triple-Negative Breast Cancer Treatment Market Size (Million USD) (2014-2025)
Figure Europe Triple-Negative Breast Cancer Treatment Market Size (Million USD) (2014-2025)
Figure China Triple-Negative Breast Cancer Treatment Market Size (Million USD) (2014-2025)
Figure Japan Triple-Negative Breast Cancer Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Triple-Negative Breast Cancer Treatment Market Size (Million USD) (2014-2025)
Figure India Triple-Negative Breast Cancer Treatment Market Size (Million USD) (2014-2025)
Table Triple-Negative Breast Cancer Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Triple-Negative Breast Cancer Treatment in 2018
Figure Manufacturing Process Analysis of Triple-Negative Breast Cancer Treatment
Figure Industry Chain Structure of Triple-Negative Breast Cancer Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Triple-Negative Breast Cancer Treatment Manufacturing Plants Distribution
Table Triple-Negative Breast Cancer Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Triple-Negative Breast Cancer Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Triple-Negative Breast Cancer Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Triple-Negative Breast Cancer Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Triple-Negative Breast Cancer Treatment Production Share by Manufacturers in 2018
Table Triple-Negative Breast Cancer Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Triple-Negative Breast Cancer Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Triple-Negative Breast Cancer Treatment Revenue Share by Manufacturers in 2018
Table Triple-Negative Breast Cancer Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Triple-Negative Breast Cancer Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Triple-Negative Breast Cancer Treatment Production Market Share by Regions 2014-2019
Figure Global Triple-Negative Breast Cancer Treatment Production Market Share by Regions in 2018
Table Global Triple-Negative Breast Cancer Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Regions 2014-2019
Figure Global Triple-Negative Breast Cancer Treatment Revenue Market Share by Regions in 2018
Table Global Triple-Negative Breast Cancer Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Triple-Negative Breast Cancer Treatment Consumption Market Share by Regions 2014-2019
Figure North America Triple-Negative Breast Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Triple-Negative Breast Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Triple-Negative Breast Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Triple-Negative Breast Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Triple-Negative Breast Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Triple-Negative Breast Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure China Triple-Negative Breast Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Triple-Negative Breast Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Triple-Negative Breast Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Triple-Negative Breast Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Triple-Negative Breast Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Triple-Negative Breast Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Triple-Negative Breast Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Triple-Negative Breast Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Triple-Negative Breast Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure India Triple-Negative Breast Cancer Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Triple-Negative Breast Cancer Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Triple-Negative Breast Cancer Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Triple-Negative Breast Cancer Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Triple-Negative Breast Cancer Treatment Market Share by Application (2014-2019)
Table Celgene Triple-Negative Breast Cancer Treatment Production Sites and Area Served
Table Celgene Triple-Negative Breast Cancer Treatment Product Introduction, Application and Specification
Table Celgene Triple-Negative Breast Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Triple-Negative Breast Cancer Treatment Production Growth Rate (2014-2019)
Table Celgene Triple-Negative Breast Cancer Treatment Production Market Share (2014-2019)
Figure Celgene Triple-Negative Breast Cancer Treatment Revenue Market Share (2014-2019)
Table Celgene Triple-Negative Breast Cancer Treatment Main Business and Markets Served
Table Roche Triple-Negative Breast Cancer Treatment Production Sites and Area Served
Table Roche Triple-Negative Breast Cancer Treatment Product Introduction, Application and Specification
Table Roche Triple-Negative Breast Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Triple-Negative Breast Cancer Treatment Production Growth Rate (2014-2019)
Table Roche Triple-Negative Breast Cancer Treatment Production Market Share (2014-2019)
Figure Roche Triple-Negative Breast Cancer Treatment Revenue Market Share (2014-2019)
Table Roche Triple-Negative Breast Cancer Treatment Main Business and Markets Served
Table Immunomedics GmbH Triple-Negative Breast Cancer Treatment Production Sites and Area Served
Table Immunomedics GmbH Triple-Negative Breast Cancer Treatment Product Introduction, Application and Specification
Table Immunomedics GmbH Triple-Negative Breast Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Immunomedics GmbH Triple-Negative Breast Cancer Treatment Production Growth Rate (2014-2019)
Table Immunomedics GmbH Triple-Negative Breast Cancer Treatment Production Market Share (2014-2019)
Figure Immunomedics GmbH Triple-Negative Breast Cancer Treatment Revenue Market Share (2014-2019)
Table Immunomedics GmbH Triple-Negative Breast Cancer Treatment Main Business and Markets Served
Table Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Production Sites and Area Served
Table Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Product Introduction, Application and Specification
Table Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Production Market Share (2014-2019)
Figure Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Triple-Negative Breast Cancer Treatment Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd Triple-Negative Breast Cancer Treatment Main Business and Markets Served
Table Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Production Sites and Area Served
Table Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Product Introduction, Application and Specification
Table Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Production Growth Rate (2014-2019)
Table Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Production Market Share (2014-2019)
Figure Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Revenue Market Share (2014-2019)
Table Eisai Co., Ltd Triple-Negative Breast Cancer Treatment Main Business and Markets Served
Figure Global Triple-Negative Breast Cancer Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Triple-Negative Breast Cancer Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Triple-Negative Breast Cancer Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Triple-Negative Breast Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Triple-Negative Breast Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Triple-Negative Breast Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Triple-Negative Breast Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Triple-Negative Breast Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Triple-Negative Breast Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Triple-Negative Breast Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Triple-Negative Breast Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Triple-Negative Breast Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Triple-Negative Breast Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Triple-Negative Breast Cancer Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Triple-Negative Breast Cancer Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Triple-Negative Breast Cancer Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Triple-Negative Breast Cancer Treatment by Application (2019-2025)
Table Triple-Negative Breast Cancer Treatment Distributors List
Table Triple-Negative Breast Cancer Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Celgene、Roche、Immunomedics GmbH、Merck & Co., Inc.、F. Hoffmann-La Roche Ltd、Eisai Co., Ltd、

★調査レポート[世界のトリプルネガティブ乳癌治療市場 2019年] (コード：DATA909X16858)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトリプルネガティブ乳癌治療市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 乳がん診断および薬物技術の世界市場：規模・現状・予測2019-2025
    DATA909X18241 / QYResearch / 2019年11月25日 / ※当調査レポートでは、乳がん診断および薬物技術の世界市場について調査・分析し、乳がん診断および薬物技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（マンモグラフィ、生検、その他）、用途別（乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん診断および薬物技術市場動向 ・主要企業別マーケットシェア ・乳がん診断および薬物技術の種類別市場規模2014-2019 （マンモグラフィ、生検、その他） ・乳がん診断および薬物技術の用途別市場規模2014-2019 （乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん） ・乳がん診断および薬物技術の北米市場：主要企業・種類別/用途別市場規模 ・乳がん診断および薬物技術のヨーロッパ市場：主要企業・種類別/用途別市場規模...Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Diagnostic and Drug Technologies development in...
  • 乳がん検査の世界市場：規模・現状・予測2019-2025
    DATA909X18242 / QYResearch / 2019年11月25日 / ※当調査レポートでは、乳がん検査の世界市場について調査・分析し、乳がん検査の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（スクリーニングテスト、診断テスト、モニタリングテスト）、用途別（非浸潤性乳がん、浸潤性乳がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん検査市場動向 ・主要企業別マーケットシェア ・乳がん検査の種類別市場規模2014-2019 （スクリーニングテスト、診断テスト、モニタリングテスト） ・乳がん検査の用途別市場規模2014-2019 （非浸潤性乳がん、浸潤性乳がん） ・乳がん検査の北米市場：主要企業・種類別/用途別市場規模 ・乳がん検査のヨーロッパ市場：主要企業・種類別/用途別市場規模...Breast cancer is one of the most common malignant tumors in women, which poses a great threat to women's life and health.In recent years, as people pay more attention to women's health, the detection methods of their diseases have been greatly improved.Breast cancer tests include screening tests, diagnostic tests and monitoring tests.Screening tests, such as annual mammograms, are given regularly to people who appear healthy and who are not suspected of having breast cancer.The goal is to detect breast cancer early, before any symptoms appear, and cancer is often easier to treat.Diagnostic tests (such as biopsies) are for people suspected...
  • ホルモン抵抗性乳癌の世界市場：規模・現状・予測2019-2025
    DATA909X18546 / QYResearch / 2019年11月25日 / ※当調査レポートでは、ホルモン抵抗性乳癌の世界市場について調査・分析し、ホルモン抵抗性乳癌の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（腫瘍マーカー療法、遺伝子発現療法、遺伝子突然変異療法）、用途別（科学研究生産、生物科学技術、医療技術、医療機器）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のホルモン抵抗性乳癌市場動向 ・主要企業別マーケットシェア ・ホルモン抵抗性乳癌の種類別市場規模2014-2019 （腫瘍マーカー療法、遺伝子発現療法、遺伝子突然変異療法） ・ホルモン抵抗性乳癌の用途別市場規模2014-2019 （科学研究生産、生物科学技術、医療技術、医療機器） ・ホルモン抵抗性乳癌の北米市場：主要企業・種類別/用途別市場規模 ・ホルモン抵抗性乳癌のヨーロッパ市場：主要企業・種類別/用途別市場規模...An increasing number of hormone therapies have made refractory breast cancer resistant to treatment, increased incidence of breast cancer, aging population, increased demand for advanced therapies, increased incidence of hormone-refractory breast cancer and the existence of a large number of anti-cancer pipeline drugs, all of which drive the growth of hormone-refractory breast cancer market.In 2018, the global Hormone Refractory Breast Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Hormone Refractory Breast Cancer status, future...

    • ◆H&Iグローバルリサーチのお客様（例）◆